false
Catalog
Substance Use in Aging: Recognizing & Treating Add ...
View Presentation Slides
View Presentation Slides
Back to course
Pdf Summary
The presentation by Dr. Louis A. Trevisan addresses substance-related and addictive disorders among older adults, focusing on increasing prevalence, identifying symptoms, and evidence-based treatments. The term "Older Adults" is preferred over "Elderly" to describe this group, generally including individuals over 50-55 years.<br /><br />Substance use among older Americans includes tobacco, alcohol, opioids, stimulants, and cannabis use, with significant health impacts. For example, smoking and alcohol use remain prevalent in middle-aged and older groups, with recent increases in high-risk drinking and Alcohol Use Disorder (AUD) especially noted in the context of the COVID-19 pandemic. Opioid use and overdose deaths continue to rise, often involving prescription misuse.<br /><br />Recognition of substance misuse in older adults requires awareness of potential barriers such as co-morbidity masking symptoms, age-related changes, and fewer overt signs. Screenings using tools like FTND for tobacco, AUDIT for alcohol, and SOAPP-R for opioids are recommended for identifying misuse.<br /><br />Treatment of substance use disorders (SUD) in older adults necessitates tailored approaches. This includes both pharmacological interventions, like nicotine replacement therapy, naltrexone for AUD, and methadone or buprenorphine for opioid dependence, as well as psychotherapeutic interventions focusing on psychosocial stressors, life changes, and motivational strategies. Implementing age-specific treatments that address cognitive abilities, social support, and individual therapy enhances efficacy.<br /><br />Ultimately, effective SUD treatment in older adults involves a comprehensive, empathetic approach that respects the demographic's unique needs and challenges.
Keywords
substance-related disorders
addictive disorders
older adults
substance use
evidence-based treatments
high-risk drinking
opioid use
AUDIT screening
pharmacological interventions
psychotherapeutic interventions
×
Please select your language
1
English